188 related articles for article (PubMed ID: 16002727)
1. Elimination of senescent neutrophils by TNF-related apoptosis-inducing [corrected] ligand.
Lum JJ; Bren G; McClure R; Badley AD
J Immunol; 2005 Jul; 175(2):1232-8. PubMed ID: 16002727
[TBL] [Abstract][Full Text] [Related]
2. Acceleration of human neutrophil apoptosis by TRAIL.
Renshaw SA; Parmar JS; Singleton V; Rowe SJ; Dockrell DH; Dower SK; Bingle CD; Chilvers ER; Whyte MK
J Immunol; 2003 Jan; 170(2):1027-33. PubMed ID: 12517970
[TBL] [Abstract][Full Text] [Related]
3. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils.
Kamohara H; Matsuyama W; Shimozato O; Abe K; Galligan C; Hashimoto S; Matsushima K; Yoshimura T
Immunology; 2004 Feb; 111(2):186-94. PubMed ID: 15027904
[TBL] [Abstract][Full Text] [Related]
4. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand.
Chou AH; Tsai HF; Lin LL; Hsieh SL; Hsu PI; Hsu PN
J Immunol; 2001 Aug; 167(3):1347-52. PubMed ID: 11466352
[TBL] [Abstract][Full Text] [Related]
5. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells.
Zhang XD; Franco AV; Nguyen T; Gray CP; Hersey P
J Immunol; 2000 Apr; 164(8):3961-70. PubMed ID: 10754286
[TBL] [Abstract][Full Text] [Related]
6. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis.
Hilliard B; Wilmen A; Seidel C; Liu TS; Göke R; Chen Y
J Immunol; 2001 Jan; 166(2):1314-9. PubMed ID: 11145715
[TBL] [Abstract][Full Text] [Related]
7. TRAIL/Apo-2 ligand induces primary plasma cell apoptosis.
Ursini-Siegel J; Zhang W; Altmeyer A; Hatada EN; Do RK; Yagita H; Chen-Kiang S
J Immunol; 2002 Nov; 169(10):5505-13. PubMed ID: 12421926
[TBL] [Abstract][Full Text] [Related]
8. Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis.
Suratt BT; Petty JM; Young SK; Malcolm KC; Lieber JG; Nick JA; Gonzalo JA; Henson PM; Worthen GS
Blood; 2004 Jul; 104(2):565-71. PubMed ID: 15054039
[TBL] [Abstract][Full Text] [Related]
9. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence.
Martin C; Burdon PC; Bridger G; Gutierrez-Ramos JC; Williams TJ; Rankin SM
Immunity; 2003 Oct; 19(4):583-93. PubMed ID: 14563322
[TBL] [Abstract][Full Text] [Related]
10. GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo.
Vroon A; Heijnen CJ; Raatgever R; Touw IP; Ploemacher RE; Premont RT; Kavelaars A
J Leukoc Biol; 2004 Apr; 75(4):698-704. PubMed ID: 14704365
[TBL] [Abstract][Full Text] [Related]
11. Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway.
Colamussi ML; Secchiero P; Gonelli A; Marchisio M; Zauli G; Capitani S
J Leukoc Biol; 2001 Feb; 69(2):263-70. PubMed ID: 11272277
[TBL] [Abstract][Full Text] [Related]
12. Acquired T-cell sensitivity to TRAIL mediated killing during HIV infection is regulated by CXCR4-gp120 interactions.
Lum JJ; Schnepple DJ; Badley AD
AIDS; 2005 Jul; 19(11):1125-33. PubMed ID: 15990565
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-derived TNF-related apoptosis-inducing ligand (TRAIL): a novel mechanism of antitumor effect by neutrophils.
Koga Y; Matsuzaki A; Suminoe A; Hattori H; Hara T
Cancer Res; 2004 Feb; 64(3):1037-43. PubMed ID: 14871835
[TBL] [Abstract][Full Text] [Related]
14. TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages.
Kaplan MJ; Ray D; Mo RR; Yung RL; Richardson BC
J Immunol; 2000 Mar; 164(6):2897-904. PubMed ID: 10706675
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between CXCR4/stromal derived factor-1 and VLA-4/VCAM-1 pathways regulates neutrophil retention in the bone marrow.
Petty JM; Lenox CC; Weiss DJ; Poynter ME; Suratt BT
J Immunol; 2009 Jan; 182(1):604-12. PubMed ID: 19109194
[TBL] [Abstract][Full Text] [Related]
16. On the production of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2L) by human neutrophils.
Cassatella MA
J Leukoc Biol; 2006 Jun; 79(6):1140-9. PubMed ID: 16574768
[TBL] [Abstract][Full Text] [Related]
17. Expression of tumor necrosis factor- alpha -related apoptosis-inducing ligand and its proapoptotic receptors is down-regulated during gastric infection with virulent cagA+/vacAs1+ Helicobacter pylori strains.
Neu B; Rad R; Reindl W; Neuhofer M; Gerhard M; Schepp W; Prinz C
J Infect Dis; 2005 Feb; 191(4):571-8. PubMed ID: 15655781
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of the expression of CD95 ligand, receptor activator of nuclear factor-kappa B ligand (RANKL), TNF-related apoptosis-inducing ligand (TRAIL), and TNF-alpha during T cell activation.
Wang R; Zhang L; Zhang X; Moreno J; Luo X; Tondravi M; Shi Y
J Immunol; 2001 Feb; 166(3):1983-90. PubMed ID: 11160247
[TBL] [Abstract][Full Text] [Related]
19. The involvement of TNF-alpha-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-beta-stimulated human dendritic cells to tumor cells.
Liu S; Yu Y; Zhang M; Wang W; Cao X
J Immunol; 2001 May; 166(9):5407-15. PubMed ID: 11313377
[TBL] [Abstract][Full Text] [Related]
20. TRAIL-induced cell death cooperates with IFN-gamma activation in the graft-versus-tumor effect against colon tumors.
Tateishi K; Ohta M; Guleng B; Kanai F; Tanaka Y; Asaoka Y; Jazag A; Imamura J; Imamura T; Ijichi H; Ikenoue T; Kawakami T; Fukushima Y; Washida M; Sata M; Miyagishi M; Taira K; Yoshida H; Kawabe T; Omata M
Int J Cancer; 2006 May; 118(9):2237-46. PubMed ID: 16331624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
